Hepatitis B is a serious liver infection caused by the hepatitis B virus (HBV). It is a contagious virus that can be transmitted through contact with blood or other body fluids of an infected person. The virus affects the liver, causing inflammation, scarring, and, in some cases, cancer. The virus is spread mainly through contact with infected blood, unprotected sex, and sharing needles and syringes. The World Health Organization estimates that more than 240 million people are chronically infected with HBV. It is a major public health problem and is the leading cause of chronic liver disease and liver cancer worldwide. The diagnosis of hepatitis B is based on the presence of specific antibodies in the blood. The most commonly used test to detect hepatitis B is the hepatitis B surface antibody (HbsAb) test. This test detects the presence of antibodies to the surface antigen of the hepatitis B virus. It is used to determine whether a person has been infected with the virus and is a key part of screening for hepatitis B.
The HbsAb test is a blood test used to detect the presence of antibodies to the surface antigen of the hepatitis B virus. It is used to diagnose an active or past infection with the virus and to measure the amount of virus in a person’s body. The test measures the amount of antibodies in the blood that are specific to the surface antigen of the hepatitis B virus. If the test is positive, it means that the person has been infected with the virus. The HbsAb test is usually the first test performed when screening for hepatitis B. It is used to determine whether a person has been exposed to the virus and to measure the amount of virus in the body. A positive result indicates that the person has been exposed to the virus and has developed antibodies to the surface antigen of the virus. A negative result indicates that the person has not been exposed to the virus.
The HbsAb test is used to diagnose an active or past infection with the hepatitis B virus. It is also used to monitor the effectiveness of treatment for those who are infected. The test is also used to screen for hepatitis B in people who are at risk of infection, such as healthcare workers, people with multiple sexual partners, and intravenous drug users. The HbsAb test is also used to measure the amount of virus in a person’s body. A high level of antibodies in the blood indicates that the virus is actively replicating and that the person is more likely to transmit the virus to others. A low level of antibodies indicates that the virus is not actively replicating and that the person is less likely to transmit the virus to others.
The HbsAb test is an important tool for diagnosing and monitoring hepatitis B infection. It is used to determine whether a person has been exposed to the virus and to measure the amount of virus in the body. A positive result indicates that the person has been exposed to the virus and has developed antibodies to the surface antigen of the virus. A negative result indicates that the person has not been exposed to the virus. The test is also used to monitor the effectiveness of treatment for those who are infected and to screen for hepatitis B in people who are at risk of infection. The HbsAb test is a valuable tool for quantifying hepatitis B surface antibody levels and helping to prevent the spread of this serious virus.
1.
How wildfires pose challenges to cancer care
2.
AI model combines clinical and magnetic resonance data to improve prediction of breast cancer recurrence
3.
A researcher has found that yoga exhibits the "most improvement" in helping long-term cancer survivors restore their brain health.
4.
Detecting pancreatic cancer through changes in body composition and metabolism
5.
For the treatment of vestibular schwannomas in neurofibromatosis type 2, stereotactic radiosurgery has been found to be effective.
1.
Personalized Survivorship Care in Older Adults with Cancer
2.
Epigenetic Signatures for Multi-Cancer Screening
3.
Robotic Intratumoral Resection for Organ Preservation: Advances, Evidence, and Clinical Implications
4.
Intrapancreatic Fat, Pancreatitis, and Cancer: Role of Cancer-Associated Fibroblasts
5.
Colon Cancer Staging: What You Need to Know
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation